Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Theravance Biopharma, Inc. | StockGist | StockGist

Companies
TBPH
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings TBPHSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Theravance Biopharma, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001583107

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

1,621,100

Reporting Person

Theravance Biopharma, Inc.

Person Type

IA

Key Facts

Shares Owned

1,621,100

Recent Filings

Theravance Biopharma, Inc.1 weeks ago

Theravance Biopharma, Inc.2 weeks ago

Theravance Biopharma, Inc.2 weeks ago

Theravance Biopharma, Inc.1 months ago

Theravance Biopharma, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice